Global Male Hypogonadism Market 2022: North America to Remain Largest Market for Male Hypogonadism

According to Persistence Market Research's new report, global male hypogonadism market is slated to exhibit a steady expansion throughout the forecast period (2017-2026). Revenues from the global market for male hypogonadism are estimated to exceed US$ 3,300 Mn by 2026-end.

Request For Free Sample Report of "Male Hypogonadism Market"@ https://www.persistencemarketresearch.com/samples/22303

Governments Taking Initiatives to Spread Awareness about Male Hypogonadism Therapeutics

Lack of sex hormones, usually referred to as male hypogonadism has resulted into many health risks that include osteoporosis, heart disease, and cardiovascular diseases on the back of thinning of bones. Global male hypogonadism market comprises several patented brands that currently have high market penetration. Proliferation in geriatric population in tandem with rising incidences related to rheumatoid arthritis and obesity have been primary factors affecting prevalence of male hypogonadism globally. Mounting incidences of testosterone deficiency in male population is a key factor that prevalence of male hypogonadism has surged worldwide. Several governments around the world have been taking initiatives to spread the awareness on hypogonadism treatment procedures, for example - testosterone replacement therapy (TST), in order to relieve the painful burden on patients and their families.

As low testosterone levels are increasingly associated with exacerbation of chronic conditions, it further results into disorders apropos to hypothalamic-pituitary-gonadal axis. Advent of TST has however enabled reduction in cases of male hypogonadism considerably. With growing awareness related to its treatment among patients, the market is likely to gain an uptick during the forecast period. Rising availability of the selective androgen receptor modulators (SARMs) has further sustained the market expansion. The development and high availability of SARMs has led toward the provision of improved treatment procedure to patients having androgen deficiencies, thereby influencing the market growth.

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/22303

North America will continue to Dominate Global Male Hypogonadism Market

North America will continue to dominate the global male hypogonadism market, with more than one-third revenue share during the forecast period. In addition, revenues from the male hypogonadism market in North America will exhibit the fastest expansion through 2026, as compared to those from all the other regional segments comprised in the report. Europe and Asia-Pacific excluding Japan (APEJ) are also expected to remain lucrative for the male hypogonadism market. The market in APEJ will ride on a slightly higher CAGR than that in Europe through 2026.

Topical gels are expected to remain the most lucrative among drugs available for treatment of male hypogonadism globally, with sales projected to register the fastest expansion through 2026. Injectables will also remain a major revenue contributor to the market. Sales of injectable and transdermal patches are poised to reflect an equal CAGR through 2026.

Companies

Endo International Plc

Eli Lilly and Company Ltd.

AbbVie, Inc.

Pfizer, Inc.

Merck KGaA

Allergan Plc

Sun Pharmaceutical Industries Limited

Ferring B.V.

Others

Request Customization @ https://www.persistencemarketresearch.com/request-customization/22303

Key Questions Answered in This Report.

What are the Roadblocks for Male Hypogonadism Market Suppliers?
What are the Key Opportunities for Male Hypogonadism Market Manufacturers?
How is Focus on Safety Influencing Male Hypogonadism Market Demand?
What is the Regulatory Impact on Global Sales of Male Hypogonadism Market?
Which Region Offers the Largest Opportunity for Sales of Male Hypogonadism Market?
Where Does the U.S. Stand in the Market for Male Hypogonadism Market?
What Is the Outlook for Male Hypogonadism Market Manufacturers in China?
Why is Germany a Lucrative Market for Male Hypogonadism Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Male Hypogonadism Market?
Why is There High Demand for Tires in Male Hypogonadism Market?
Why are Sales of Male Hypogonadism Market Surging?

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.